Follow
Young Kee Shin
Title
Cited by
Cited by
Year
TMEM16A confers receptor-activated calcium-dependent chloride conductance
UO Yang YD, Cho H, Koo JY, Tak MH, Cho Y, Shim W-S, Park SP, Lee J, Lee B ...
Nature 455 (7217), 1210-1215, 2008
14402008
[6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin
SO Kim, JK Kundu, YK Shin, JH Park, MH Cho, TY Kim, YJ Surh
Oncogene 24 (15), 2558-2567, 2005
3632005
Loss of tumor suppressor gene function in human cancer: an overview
LH Wang, CF Wu, N Rajasekaran, YK Shin
Cellular Physiology and Biochemistry 51 (6), 2647-2693, 2019
3462019
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity
JK Kundu, YK Shin, SH Kim, YJ Surh
Carcinogenesis 27 (7), 1465-1474, 2006
3372006
Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets
JK Kundu, YK Shin, YJ Surh
Biochemical pharmacology 72 (11), 1506-1515, 2006
2262006
Human lysyl-tRNA synthetase is secreted to trigger pro-inflammatory response
SG Park, HJ Kim, YH Min, EC Choi, YK Shin, BJ Park, SW Lee, S Kim
Proceedings of the National Academy of Sciences 102 (18), 6356-6361, 2005
2152005
Liver X receptor mediates hepatitis B virus X protein–induced lipogenesis in hepatitis B virus–associated hepatocellular carcinoma
TY Na, YK Shin, KJ Roh, SA Kang, I Hong, SJ Oh, JK Seong, CK Park, ...
Hepatology 49 (4), 1122-1131, 2009
1902009
High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients
S Park, YL Choi, CO Sung, J An, J Seo, MJ Ahn, JS Ahn, K Park, YK Shin, ...
F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de …, 2012
1792012
Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells
YG Yoo, TY Na, HW Seo, JK Seong, CK Park, YK Shin, MO Lee
Oncogene 27 (24), 3405-3413, 2008
1782008
LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer
YL Choi, M Bocanegra, MJ Kwon, YK Shin, SJ Nam, JH Yang, J Kao, ...
Cancer research 70 (6), 2296-2306, 2010
1702010
The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR
BJ Park, JW Kang, SW Lee, SJ Choi, YK Shin, YH Ahn, YH Choi, D Choi, ...
Cell 120 (2), 209-221, 2005
1662005
The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma
JKM Lennerz, SH Kim, EL Oates, WJ Huh, JM Doherty, X Tian, ...
The American journal of pathology 177 (3), 1514-1533, 2010
1372010
Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression
LH Wang, SH Kim, JH Lee, YL Choi, YC Kim, TS Park, YC Hong, CF Wu, ...
Clinical cancer research 13 (1), 102-110, 2007
1332007
Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis
MJ Kwon, E Oh, S Lee, MR Roh, SE Kim, Y Lee, YL Choi, YH In, T Park, ...
PloS one 4 (7), e6162, 2009
1232009
The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair
SG Park, H Shin, YK Shin, Y Lee, EC Choi, BJ Park, S Kim
The American journal of pathology 166 (2), 387-398, 2005
1222005
Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions
LH Wang, YL Choi, XY Hua, YK Shin, YJ Song, SJ Youn, HY Yun, ...
Modern Pathology 19 (5), 675-683, 2006
1162006
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis
JW Choi, DG Kim, AE Lee, HR Kim, JY Lee, NH Kwon, YK Shin, ...
PLoS genetics 7 (3), e1001351, 2011
1122011
Comparison of accuracy of whole-exome sequencing with formalin-fixed paraffin-embedded and fresh frozen tissue samples
E Oh, YL Choi, MJ Kwon, RN Kim, YJ Kim, JY Song, KS Jung, YK Shin
PloS one 10 (12), e0144162, 2015
1052015
Regulation of ovarian cancer stem cells or tumor-initiating cells
MJ Kwon, YK Shin
International journal of molecular sciences 14 (4), 6624-6648, 2013
992013
MET is a potential target for use in combination therapy with EGFR inhibition in triple‐negative/basal‐like breast cancer
YJ Kim, JS Choi, J Seo, JY Song, S Eun Lee, MJ Kwon, MJ Kwon, ...
International journal of cancer 134 (10), 2424-2436, 2014
982014
The system can't perform the operation now. Try again later.
Articles 1–20